Biongevity, the first precision health and longevity clinic in Dubai, UAE, has commenced operations, setting a new benchmark in the UAE region's healthcare landscape.

The clinic, which opened on 13 September 2024, is dedicated to delivering personalised healthcare by integrating advanced genomics, AI insights, as well as comprehensive data analysis to enhance the health span and life quality of individuals.

In a press release, shared by Zawya, the company said that a multi-disciplinary team of medical experts at Biongevity collaborates to provide holistic care, covering a range of specialties.

Some of these specialities include general practice, cardiology, internal medicine, dermatology, and gastroenterology. Each speciality is focused on crafting individualised healthcare strategies for patients.

Technologies such as PanomiQ and BioELR are some of the key Biongevity offerings, enabling detailed health evaluations and customised treatment plans.

By fusing AI algorithms with multi-omics data, the clinic's methodology represents a significant advancement in the fields of precision medicine and longevity research. 

Additionally, the Virtual Hypertension Clinic offers patients the convenience of receiving personalised care from a distance.

To complement its clinical services, Biongevity provides Longevity Plus Supplements, which are designed to support sustained health and vitality based on scientific research. 

The inauguration of Biongevity is in line with the UAE's strategic objectives to enhance genomics and preventive medicine.

Biongevity cardiologist and founder Dr Anmol Kapoor said: “Our clinic’s mission reflects the UAE’s dedication to fostering innovation in healthcare, particularly in genomics and longevity science. We aim to make Dubai a global hub for precision health, benefiting not only local residents but also international visitors seeking advanced healthcare solutions.”

According to the company, the Emirati Genome Programme is instrumental to this vision, utilising DNA sequencing and AI to study the genetic profiles of Emiratis to create a reference genome that will facilitate the development of tailored healthcare and new treatments.

Following its successful debut in Dubai, Biongevity has outlined extensive plans for growth, with new clinics expected to open in key cities within the Gulf Cooperation Council, as well as in Silicon Valley, London, and Toronto by 2026.